The Child Anxiety Prevention Study: Intervention Model and Primary Outcomes
Overview
Authors
Affiliations
The article presents the intervention model and primary outcomes of a preventive intervention designed to reduce anxiety symptoms and prevent the onset of anxiety disorders in the offspring of parents with anxiety disorders. Participants were 40 volunteer children (mean age = 8.94 years; 45% girls; 90% Caucasian) whose parents met criteria for a broad range of anxiety disorders. Families were randomly assigned to an 8-week cognitive-behavioral intervention, the Coping and Promoting Strength program (CAPS; n = 20) or a wait list control condition (WL; n = 20). Independent evaluators (IEs) conducted diagnostic interviews, and children and parents completed measures of anxiety symptoms. Assessments were conducted pre- and postintervention and 6 and 12 months after the postintervention assessment. On the basis of intent to treat analyses, 30% of the children in the WL group developed an anxiety disorder by the 1-year follow-up compared with 0% in the CAPS group. IE and parent-reported (but not child-reported) levels of anxiety showed significant decreases from the preintervention assessment to the 1-year follow-up assessment in the CAPS but not the WL group. Parental satisfaction with the intervention was high. Findings suggest that a family-based intervention may prevent the onset of anxiety disorders in the offspring of parents with anxiety disorders.
The Utility of Clinicians Ratings of Anxiety Using the Pediatric Anxiety Rating Scale (PARS).
Ginsburg G, Keeton C, Drazdowski T, Riddle M Child Youth Care Forum. 2024; 40(2):93-105.
PMID: 39015750 PMC: 11250771. DOI: 10.1007/s10566-010-9125-3.
Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis.
Kowalec K, Harder A, Dolovich C, Fitzgerald K, Salter A, Lu Y Ann Clin Transl Neurol. 2024; 11(6):1393-1404.
PMID: 38715244 PMC: 11187942. DOI: 10.1002/acn3.52025.
The chemokine XCL1 functions as a pregnancy hormone to program offspring innate anxiety.
Chen R, Nabila A, Gal Toth J, Stuhlmann H, Toth M Brain Behav Immun. 2024; 118:178-189.
PMID: 38428650 PMC: 11044916. DOI: 10.1016/j.bbi.2024.02.032.
Moltrecht B, Lange A, Merrick H, Radley J Eur Child Adolesc Psychiatry. 2024; 33(9):3203-3246.
PMID: 38393370 PMC: 11424744. DOI: 10.1007/s00787-024-02380-3.
Zhang N, Smith I, Ginsburg G Child Psychiatry Hum Dev. 2024; .
PMID: 38206536 DOI: 10.1007/s10578-023-01657-z.